News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Week in Review: Amgen (AMGN) Partners With ShanghaiTech on China R&D Center


9/30/2013 8:57:03 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

by Richard Daverman, PhD

September 28, 2013 --Amgen signed a MOU with ShanghaiTech University under which Amgen will locate R&D centers at two of the university’s institutes; JHL Biotech, a Taiwan startup formed by Genentech veterans, will build a biologic manufacturing facility in Wuhan’s Biolake Park; Shenzhen device maker Mindray Medical acquired Ulco Medical, its distributor in Australia, New Zealand and Oceana; Sinochem Jiangsu Pharma acquired China distribution rights for generic mecobalamin tablets from Suzhou Amerigen Pharma; Boehringer Ingelheim completed a $95 million expansion of its Shanghai production facility; and Shenzhen is proposing to build a new biotech park, Shenzhen International Bio-Valley. More details....

Stock Symbols: (NSDQ: AMGN) (NYSE: MR)

Help employers find you! Check out all the jobs and post your resume.

Read at ChinaBio Today

comments powered by Disqus
Amgen
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES